Clinical Trial Update: ATAQ EASY: Artesunate + Amodiaquine Fixed Dose Combination in the Treatment of Uncomplicated Plasmodium Falciparum Malaria [Phase 3]

View source ↗

Summary

Phase 3 trial assessing the fixed-dose artesunate + amodiaquine combination (ATAQ EASY) for uncomplicated Plasmodium falciparum malaria has completed, with Sano…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Plasmodium Falciparum Malaria

Drugs mentioned

• Amodiaquine (Amodiaquine)
• Artesunate (artesunate)

Snippet

Sponsor: Sanofi | Conditions: Malaria | Phase 3 | Status: COMPLETED